Belsomra and Sinusitis - acute - a phase IV clinical study of FDA data

Summary:

Sinusitis - acute is reported as a side effect among people who take Belsomra (suvorexant), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Vitamin D3, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Sinusitis - acute when taking Belsomra. It is created by eHealthMe based on reports of 12,886 people who have side effects when taking Belsomra from the FDA, and is updated regularly.

What is Belsomra?

Belsomra has active ingredients of suvorexant. It is often used in insomnia. eHealthMe is studying from 12,961 Belsomra users. Check the latest studies of Belsomra.

What is Sinusitis - acute?

Sinusitis - acute is found to be associated with 3,395 drugs and 2,776 conditions by eHealthMe. Check the latest studies of Sinusitis - acute.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

12,886 people reported to have side effects when taking Belsomra.
Among them, 40 people (0.31%) have Sinusitis - acute.

Among these 40 people:

How long have people been on Belsomra when they have Sinusitis - acute? *

What is the gender of people who have Sinusitis - acute when taking Belsomra? *

female: 89.74 %
male: 10.26 %

What is the age of people who have Sinusitis - acute when taking Belsomra? *

What are other drugs people take besides Belsomra? *

What are other side effects people have besides Sinusitis - acute? *

Otitis (ear infection): 19 people, 47.50%
Headache (pain in head): 17 people, 42.50%
Urinary Tract Infection: 14 people, 35.00%
Kidney Infection: 10 people, 25.00%
Upper Respiratory Tract Infection: 9 people, 22.50%
Depression: 8 people, 20.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 8 people, 20.00%
Itching: 8 people, 20.00%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 8 people, 20.00%
Rashes (redness): 7 people, 17.50%

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 11 people, 27.50%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 11 people, 27.50%
Immunodeficiency Common Variable: 11 people, 27.50%
Drowsiness: 9 people, 22.50%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 6 people, 15.00%
Fibromyalgia (a long-term condition which causes pain all over the body): 5 people, 12.50%
Migraine (headache): 4 people, 10.00%
Infection: 3 people, 7.50%
Asthma: 2 people, 5.00%
Urinary Hesitation (difficulty in beginning the flow of urine): 1 person, 2.50%

* Approximation only. Some reports may have incomplete information.

Do you take Belsomra and have Sinusitis - acute?

- Check whether Sinusitis - acute is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Belsomra:

Belsomra (12,961 reports)

Sinusitis - acute treatments and more:

Sinusitis - acute (153,485 reports)

Browse all side effects of Belsomra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sinusitis - acute:

Sinusitis - acute (3,395 drugs)

Browse all the conditions that are associated with Sinusitis - acute:

Sinusitis - acute (2,776 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on suvorexant (the active ingredients of Belsomra) and Belsomra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.